Deciphera Pharmaceuticals Inc (DCPH)

전일 마감가:

$25.37

열려 있는:

$25.39

하루 거래량:

1.83M

시가총액:

$2.09B

수익:

$163.36M

순이익/손실:

$-194.94M

주가수익비율:

-10.80

EPS:

-2.35

순현금흐름:

$-147.48M

1주 성능:

-0.04%

1개월 성능:

+62.21%

6개월 성능:

+124.31%

1년 성능:

+82.26%

1일 변동 폭

$25.36

$25.40

52주 변동 폭

$9.90

$25.47

Deciphera Pharmaceuticals Inc Stock (DCPH) Company Profile

명칭

Deciphera Pharmaceuticals Inc

부문

Healthcare (1213)

산업

Drug Manufacturers - Specialty & Generic (3)

전화

781-209-6400

주소

500 Totten Pond Road, 6th Floor, Waltham, MA

직원

63

트위터

@Deciphera

다음 수익 날짜

2024-06-03

최신 SEC 제출 서류

DCPH's Discussions on Twitter

Deciphera Pharmaceuticals Inc Stock (DCPH) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-11-20	재개	JP Morgan	Neutral
2023-10-30	업그레이드	Piper Sandler	Neutral → Overweight
2023-08-10	업그레이드	Stifel	Hold → Buy
2023-01-04	업그레이드	Guggenheim	Neutral → Buy
2022-08-29	개시	Cowen	Outperform
2022-08-05	업그레이드	JMP Securities	Mkt Perform → Mkt Outperform
2022-02-28	다운그레이드	Barclays	Equal Weight → Underweight
2021-11-08	다운그레이드	Barclays	Overweight → Equal Weight
2021-11-08	다운그레이드	Canaccord Genuity	Buy → Hold
2021-11-08	다운그레이드	Stifel	Buy → Hold
2021-11-05	다운그레이드	Truist	Buy → Hold
2021-09-30	재개	Stifel	Buy
2021-03-31	개시	Credit Suisse	Outperform
2021-02-10	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-12-03	개시	Stifel	Buy
2020-09-14	재개	JP Morgan	Neutral
2020-05-07	다운그레이드	Nomura	Buy → Neutral
2020-03-04	개시	Barclays	Overweight
2019-12-20	재확인	Jefferies	Buy
2019-10-29	업그레이드	SVB Leerink	Underperform → Mkt Perform
2019-10-22	개시	JMP Securities	Mkt Outperform
2019-10-03	개시	H.C. Wainwright	Buy
2019-09-30	개시	Jefferies	Buy
2019-07-18	개시	Deutsche Bank	Buy
2018-12-31	업그레이드	B. Riley FBR	Neutral → Buy
2018-09-25	개시	Leerink Partners	Underperform
2018-08-29	개시	Raymond James	Outperform
2018-07-05	개시	SunTrust	Buy
2018-06-19	다운그레이드	B. Riley FBR, Inc.	Buy → Neutral
2018-02-16	개시	B. Riley FBR, Inc.	Buy
2017-10-23	개시	JMP Securities	Mkt Outperform
2017-10-23	개시	JP Morgan	Overweight
2017-10-23	개시	Nomura	Buy
2017-10-23	개시	Piper Jaffray	Overweight

모두보기

Deciphera Pharmaceuticals Inc 주식(DCPH)의 최신 뉴스

AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Wall Street Breakfast: The Week Ahead

Seeking Alpha

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine

Zacks Investment Research

Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More

Zacks Investment Research

Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)

Benzinga

US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?

Benzinga

Deciphera Pharmaceuticals Inc (DCPH) 재무 분석

Deciphera Pharmaceuticals Inc (DCPH) 매출 2024

Deciphera Pharmaceuticals Inc (DCPH) 순이익 2024

Deciphera Pharmaceuticals Inc (DCPH) 현금흐름 2024

Deciphera Pharmaceuticals Inc (DCPH) 주당 순이익 2024